Ann: Mayne Pharma CEO announces plan to retire, page-81

I am also at a loss. Not since GFC have I seen
company valuations less than cash holdings.
Richards obviously has lost his influence over
the board. This obviously forced resignation has
shown the pretender the door.
A new CEO will undoubtedly be a genuine leader
with all the requirements of Mayne. Experience,
proven track record, Innovative, who can see the
opportunities Mayne offers. Nextellis as just noted
will be a large part of the short and medium term
profits. Not the only iron in the fire by any means.
once the Sales and marketing costs are bought
under control after market share more established
. This product could be very profitable. There are
quite a few areas of product sales and South Australian
(international) expansion that will also contribute
greatly to the leaner MP being touted. I truly believe
the right CEO may transform this company in relatively
quick time into what we all investors know it is capable
of.